TransMedics to Present at the 39th Annual J.P. Morgan Healthcare Conference
ANDOVER, Mass., Dec. 24, 2020 /PRNewswire/ -- TransMedics, Inc.. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that members of the management team will present virtually at the upcoming 39th Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 13, 2020 at 5:20 p.m. Eastern Standard Time.
Event: 39th Annual J.P. Morgan Healthcare Conference
A live and archived webcast of the presentation will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/.
About TransMedics Group, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/transmedics-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301198336.html
SOURCE TransMedics Group, Inc.
Company Codes: NASDAQ-NMS:TMDX